These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28758810)

  • 61. Depot leuprorelin acetate versus danazol in the treatment of infertile women with symptomatic endometriosis.
    Rotondi M; Labriola D; Rotondi M; Ammaturo FP; Amato G; Carella C; Izzo A; Panariello S
    Eur J Gynaecol Oncol; 2002; 23(6):523-6. PubMed ID: 12556096
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Leuprolide acetate 22.5 mg 12-week depot formulation in the treatment of patients with advanced prostate cancer.
    Sharifi R; Bruskewitz RC; Gittleman MC; Graham SD; Hudson PB; Stein B
    Clin Ther; 1996; 18(4):647-57. PubMed ID: 8879893
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Does needle size matter? Patient experience of luteinising hormone-releasing hormone analogue injection.
    Montgomery BS; Borwell JP; Higgins DM
    Prostate Cancer Prostatic Dis; 2005; 8(1):66-8. PubMed ID: 15700050
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate).
    Schmid P; Untch M; Wallwiener D; Kossé V; Bondar G; Vassiljev L; Tarutinov V; Kienle E; Lüftner D; Possinger K;
    Anticancer Res; 2002; 22(4):2325-32. PubMed ID: 12174922
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Injection-site granulomas resulting from the administration of both leuprorelin acetate and goserelin acetate for the treatment of prostatic cancer.
    Shiota M; Tokuda N; Kanou T; Yamasaki H
    J Nippon Med Sch; 2007 Aug; 74(4):306-8. PubMed ID: 17878701
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Leuprorelin. A review of its pharmacology and therapeutic use in prostatic disorders.
    Chrisp P; Sorkin EM
    Drugs Aging; 1991; 1(6):487-509. PubMed ID: 1794035
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of the effects of leuprorelin acetate and danazol treatments on serum CA-125 levels in women with endometriosis.
    Matalliotakis IM; Arici A; Goumenou AG; Katassos T; Karkavitsas N; Koumantakis EE
    Int J Fertil Womens Med; 2004; 49(2):75-8. PubMed ID: 15188832
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term suppression of pituitary-gonadal function with three-month depot of leuprorelin acetate in a girl with central precocious puberty.
    Schroeter M; Baus I; Sippell WG; Partsch CJ
    Horm Res; 2002; 58(6):292-6. PubMed ID: 12446994
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 3.75 and 7.5 mg leuprorelin acetate depot in the treatment of advanced prostatic cancer: preliminary report. German Leuprorelin Study Group.
    Bischoff W
    J Int Med Res; 1990; 18 Suppl 1():103-13. PubMed ID: 2108882
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Eligard: leuprolide acetate in a novel sustained-release delivery system.
    Sartor O
    Urology; 2003 Feb; 61(2 Suppl 1):25-31. PubMed ID: 12667884
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Clinical effects of a 3-month formulation LH-RH agonist, TAP-144-SR (3M) in prostate cancer patients].
    Koiso K; Yamanaka H; Ito K; Yoshinaka R; Uchida S; Yokokawa K
    Hinyokika Kiyo; 2002 Dec; 48(12):771-9. PubMed ID: 12613015
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Unusual side effect from a luteinizing hormone-releasing hormone agonist, leuprorelin, in the treatment of prostate cancer: a case report.
    Chang JI; Bucci J
    J Med Case Rep; 2016 Nov; 10(1):323. PubMed ID: 27836000
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Three-month depot of goserelin acetate: clinical efficacy and endocrine profile. Dutch South East Cooperative Urological Group.
    Fernandez del Moral P; Dijkman GA; Debruyne FM; Witjes WP; Kolvenbag GJ
    Urology; 1996 Dec; 48(6):894-900. PubMed ID: 8973673
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Complete androgen blockade versus chemical castration in advanced prostatic cancer: analysis of an Italian multicentre study. Italian Leuprorelin Group.
    Bono AV; DiSilverio F; Robustelli della Cuna G; Benvenuti C; Brausi M; Ferrari P; Gibba A; Galli L
    Urol Int; 1998; 60 Suppl 1():18-24. PubMed ID: 9563140
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Formulation study of leuprorelin acetate to improve clinical performance.
    Toguchi H
    Clin Ther; 1992; 14 Suppl A():121-30. PubMed ID: 1606592
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Skin reaction induced by subcutaneous injection of LH-RH analogue].
    Segawa N; Nishida T; Hamada S; Azuma H; Katsuoka Y; Nozaki K; Tsuji M
    Hinyokika Kiyo; 2007 Oct; 53(10):695-8. PubMed ID: 18018584
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Clinical effects of a 3-month formulation LH-RH agonist (Zoladex LA 10.8 mg depot) in patients with prostate cancer].
    Kotake T; Akaza H; Usami M; Naito S; Kanetake H; Taguchi T; Tsukagoshi S; Koiso K
    Hinyokika Kiyo; 2001 May; 47(5):349-61. PubMed ID: 11433759
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Treatment of endometriosis with leuprorelin acetate depot: a German multicentre study.
    Gerhard I; Schindler AE; Bühler K; Winkler U; Meinen K; Mancarella D; Hoffmann G; Schüssler B; Kimmig R; Kranzfelder D
    Clin Ther; 1992; 14 Suppl A():3-16. PubMed ID: 1535021
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cost comparison of orchiectomy and leuprolide in metastatic prostate cancer.
    Bonzani RA; Stricker HJ; Peabody JO; Menon M
    J Urol; 1998 Dec; 160(6 Pt 2):2446-9. PubMed ID: 9817400
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The cost value of medical versus surgical hormonal therapy for metastatic prostate cancer.
    Chon JK; Jacobs SC; Naslund MJ
    J Urol; 2000 Sep; 164(3 Pt 1):735-7. PubMed ID: 10953136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.